Despite continued interest in the development of nonsteroidal estrogens and antiestrogens, there are only a few chemotypes of estrogen receptor ligands. Using targeted screening in a ligand sensing assay, we identified a phenolic thieno[2,3-]pyrimidine with affinity for estrogen receptor α. An efficient three-step synthesis of the heterocyclic core and structure-guided optimization of the substituents resulted in a series of potent nonsteroidal estrogens. The chemical tractability of the thieno[2,3-]pyrimidine chemotype will support the design of new estrogen receptor ligands as therapeutic hormones and antihormones.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290010 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.2c00180 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!